Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 24, 2025BiomimeticsOpen Access

Integrating New Approach Methodologies (NAMs) into Preclinical Regulatory Evaluation of Oncology Drugs

View Full Paper
Ask AI
Bookmark
Share

Authors

MMMaryam Sadat MirlohiTYTooba YousefiAAAmir Reza Aref

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mirlohi et al. (2025) studied this question.

synapsesocial.com/papers/69403db02d562116f290df20https://doi.org/10.3390/biomimetics10120796
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Integrating New Approach Methodologies (NAMs) into Preclinical Regulatory Evaluation of Oncology Drugs2025 · 20 citations
  2. 2Reimagining human-centric drug development with new approach methodologies2026 · 26 citations
  3. 3Advances in New Approach Methodologies at FDA 's Division of Applied Regulatory Science2026
  4. 4Application of New Approach Methodologies to Improve Oral Biopharmaceutic Assessments2026
  5. 5New approach methodologies for drug discovery2026 · 22 citations